GPR55 Polyclonal Antibody, Cy5.5 Conjugated
Product Specifications
Background
May be involved in hyperalgesia associated with inflammatory and neuropathic pain (By similarity) . Receptor for L-alpha-lysophosphatidylinositol (LPI) . LPI induces Ca (2+) release from intracellular stores via the heterotrimeric G protein GNA13 and RHOA. Putative cannabinoid receptor. May play a role in bone physiology by regulating osteoclast number and function.
Synonyms
LPIR1; G-protein coupled receptor 55; GPR55
Gene ID
9290
Swiss Prot
Q9Y2T6
Cellular Locus
Cell membrane
Host
Rabbit
Cross Reactivity
Human
Immunogen
141-240/319
Target
GPR55
Clonality
Polyclonal
Isotype
IgG
Conjugation
Cy5.5
Source
KLH conjugated synthetic peptide derived from human GPR55
Applications
WB, IF, Flow-Cyt
Purification
Purified by Protein A.
Excitation Emission
675nm/694nm
Concentration
1µg/µl
Dilution
WB (WB=1:500-2000), IF (IF=1:100-500), Flow-Cyt (Flow-Cyt=2ug/Test)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
9290
Predicted Cross Reactivity
Mouse, Rat, Dog, Horse, Chicken, Rabbit
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
